Wellstar International, Inc. (WLSI)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Wellstar International, Inc. (WLSI) trades at $0.00 with AI Score 48/100 (Grade C). Wellstar International, Inc. is a development-stage company previously focused on thermal imaging technology for healthcare applications. Market cap: $73,713, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for WLSI: WLSI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WLSI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
WLSI: the 1 perspectives are evenly split.
How is this calculated? →Wellstar International, Inc. (WLSI) Healthcare & Pipeline Overview
Wellstar International, Inc., formerly involved in developing thermal imaging technology for early breast cancer detection and other medical applications, currently lacks significant operations and faces challenges in a competitive medical device market, reflected in its limited market capitalization and negative beta.
What Is the Investment Thesis for WLSI?
Investing in Wellstar International, Inc. presents significant risks due to its current lack of significant operations and limited market capitalization of 74K. The company's negative P/E ratio of -0.00 reflects its lack of profitability. The negative beta of -5.79 suggests an inverse correlation with the market, potentially due to its distressed state. Any investment would rely on a successful turnaround strategy, potentially involving new management, a revised business plan, or the acquisition of promising assets. However, the absence of current revenue generation and the lack of publicly available information make it difficult to assess the company's potential for future growth or profitability. Investors should carefully consider the high level of uncertainty and the potential for complete loss of investment.
Based on FMP financials and quantitative analysis
WLSI Key Highlights
- Market capitalization of 74K indicates a micro-cap company with limited investor interest.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Negative beta of -5.79 suggests an inverse correlation with the market, potentially due to its distressed state.
- The company currently has no dividend yield, reflecting its lack of profitability and cash flow.
- The company's employee count is 4, indicating a very small operation.
Who Are WLSI's Competitors?
WLSI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| EW Edwards Lifesciences Corporation | $95.44 | +1.14% | $54.96B | 58 |
| PETV PetVivo Holdings, Inc. | $0.80 | -4.65% | $24.03M | 58 |
| OWLT Owlet, Inc. | $5.91 | +2.60% | $106.94M | 58 |
| NXL Nexalin Technology, Inc. | $0.35 | -3.07% | $7.20M | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WLSI's Key Strengths?
- Potentially valuable intellectual property related to thermal imaging.
- Experienced management team (though small).
- Established presence in Holland, Ohio.
- Previous focus on a niche market with potential for growth.
What Are WLSI's Weaknesses?
- Lack of significant operations.
- Limited financial resources.
- Small employee base.
- Dependence on a single technology (thermal imaging).
What Could Drive WLSI Stock Higher?
- Potential strategic partnership or acquisition could revitalize operations.
- New product development in emerging areas of healthcare could drive growth.
- Geographic expansion into new markets could increase revenue.
- Efforts to secure licensing agreements for existing technology.
- Cost-cutting measures to improve financial performance.
What Are the Key Risks for WLSI?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and lack of significant operations.
- Intense competition in the medical device industry.
- Rapid technological advancements rendering existing technology obsolete.
- Stringent regulatory requirements.
- Economic downturn impacting healthcare spending.
What Are the Growth Opportunities for WLSI?
- Partnerships and Acquisitions: Wellstar International, Inc. could explore strategic partnerships or acquisitions to revitalize its operations. By acquiring complementary technologies or businesses, the company could expand its product portfolio and market reach. The medical device industry is ripe with opportunities for consolidation, with smaller companies often being acquired by larger players seeking to expand their capabilities. However, successful execution would require careful due diligence and integration planning. Timeline: 12-24 months.
- New Product Development: Wellstar International, Inc. could invest in developing new medical devices or technologies to address unmet needs in the healthcare market. This would require significant investment in research and development, as well as a deep understanding of market trends and regulatory requirements. The company could focus on emerging areas such as telehealth, remote patient monitoring, or personalized medicine. However, new product development is a high-risk, high-reward endeavor. Timeline: 3-5 years.
- Geographic Expansion: Wellstar International, Inc. could expand its operations into new geographic markets to increase its revenue and customer base. This would require careful market research and adaptation of its products and services to local needs. Emerging markets such as Asia and Latin America offer significant growth potential for medical device companies. However, geographic expansion can be challenging due to cultural differences, regulatory hurdles, and logistical complexities. Timeline: 2-3 years.
- Licensing Agreements: Wellstar International, Inc. could seek to license its existing thermal imaging technology to other companies in the medical device industry. This would allow the company to generate revenue without having to invest in manufacturing and distribution. Licensing agreements can be a cost-effective way to monetize intellectual property. However, the success of this strategy depends on the attractiveness of the technology and the willingness of other companies to license it. Timeline: 6-12 months.
- Focus on Niche Markets: Wellstar International, Inc. could focus on developing specialized medical devices for niche markets. This would allow the company to differentiate itself from larger competitors and capture a loyal customer base. For example, the company could develop devices for specific medical specialties or patient populations. However, niche markets may be smaller and less profitable than broader markets. Timeline: 1-2 years.
What Opportunities Does WLSI Have?
- Strategic partnerships or acquisitions to revitalize operations.
- New product development in emerging areas of healthcare.
- Geographic expansion into new markets.
- Licensing agreements to monetize existing technology.
What Threats Does WLSI Face?
- Intense competition in the medical device industry.
- Rapid technological advancements rendering existing technology obsolete.
- Stringent regulatory requirements.
- Economic downturn impacting healthcare spending.
What Are WLSI's Competitive Advantages?
- Potentially held intellectual property related to its thermal imaging technology.
- May have had established relationships with key opinion leaders in the medical field.
- First-mover advantage in specific niche applications of thermal imaging.
What Does WLSI Do?
Wellstar International, Inc., founded in 1997 and based in Holland, Ohio, was once engaged in the development and licensing of advanced thermal imaging technology through its subsidiary, Trillennium Medical Imaging, Inc. The company's focus was on consumer healthcare markets, with its technology aimed at providing diagnostic screening for early breast cancer detection, differential diagnosis of pain dysfunctions like reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders. Additionally, their technology was intended for the detection of pressure ulcers, deep tissue injuries, bed sores, and orthopedic applications. However, Wellstar International, Inc. currently does not have significant operations. The company's transition from active development and licensing to a state of limited operations raises questions about its future direction and potential for revitalization within the medical device industry. The company's past focus on thermal imaging placed it in a niche segment of the medical device market, competing with companies offering alternative diagnostic and monitoring solutions. The absence of current operations suggests challenges in commercializing its technology or adapting to evolving market demands.
What Products and Services Does WLSI Offer?
- Formerly developed thermal imaging technology for medical applications.
- Aimed to provide diagnostic screening for early breast cancer detection.
- Sought to aid in the differential diagnosis of pain dysfunctions.
- Intended to assist in the detection of pressure ulcers and deep tissue injuries.
- Explored orthopedic applications for its thermal imaging technology.
- Currently does not have significant operations.
How Does WLSI Make Money?
- Previously focused on developing and licensing thermal imaging technology.
- Aimed to generate revenue through licensing agreements with medical device manufacturers.
- Potentially sought to generate revenue through direct sales of thermal imaging devices.
What Industry Does WLSI Operate In?
Wellstar International, Inc. previously operated within the medical device industry, specifically targeting the thermal imaging segment. This market is characterized by rapid technological advancements, stringent regulatory requirements, and intense competition. Companies in this sector must continuously innovate and adapt to evolving healthcare needs to maintain a competitive edge. The absence of current operations for Wellstar International, Inc. places it at a significant disadvantage compared to established players with ongoing research and development, manufacturing, and distribution capabilities. Competitors like CNTRF and CSUI are actively engaged in the medical device market.
Who Are WLSI's Key Customers?
- Potentially targeted hospitals and clinics for diagnostic screening applications.
- May have targeted physicians specializing in pain management and orthopedics.
- Could have targeted consumers for early breast cancer detection.
ROE 6%Key Financial Metrics
Return on equity for Wellstar International, Inc. stands at 5.7%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Wellstar International, Inc. (WLSI) Valuation Context
Valued at 74K, WLSI is classified as a micro-cap stock. Relative to its peer group, WLSI's quantitative score of 48/100 is below the peer average of 69/100.
Company Profile
Wellstar International, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Holland, US. The company is led by CEO John Antonio. WLSI has traded publicly since 2006.
F-Score 2/9Financial Health
Wellstar International, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
WLSI Financials
Bull Case vs Bear Case
Bull Case
- Potentially valuable intellectual property related to thermal imaging.
- Experienced management team (though small).
- Established presence in Holland, Ohio.
- Previous focus on a niche market with potential for growth.
Bear Case
- Lack of significant operations.
- Limited financial resources.
- Small employee base.
- Dependence on a single technology (thermal imaging).
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
WLSI Latest News
No recent news available for WLSI.
WLSI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WLSI.
Price Targets
Wall Street price target analysis for WLSI.
WLSI MoonshotScore
What does this score mean?
The MoonshotScore rates WLSI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: John Antonio
Managing
John Antonio is currently managing Wellstar International, Inc. with a team of 4 employees. Information regarding his prior experience and educational background is not available. His role involves overseeing the company's operations and strategic direction, though the company currently lacks significant operations.
Track Record: Due to the company's current lack of significant operations, it is difficult to assess John Antonio's track record. His leadership will be crucial in any potential turnaround or revitalization efforts. However, there is no publicly available information regarding specific achievements or milestones under his leadership.
WLSI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Wellstar International, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may be subject to limited regulatory oversight and may not be required to file regular financial reports with the SEC. This lack of transparency can increase the risk for investors, as it may be difficult to obtain reliable information about the company's financial performance and operations. Investing in companies on the OTC Other tier requires a high degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight and disclosure requirements.
- Low liquidity and wide bid-ask spreads.
- Potential for price manipulation and fraud.
- Higher risk of financial distress or bankruptcy.
- Difficulty in obtaining reliable information about the company.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Determine if the company has an attorney of record.
- Company has been in existence since 1997.
- Company has a registered address and contact information.
- Company has a CEO/Managing person.
- Company operates in the Healthcare sector.
What Investors Ask About Wellstar International, Inc. (WLSI) — Healthcare
What does Wellstar International, Inc. do?
Wellstar International, Inc. previously focused on developing and licensing thermal imaging technology for various medical applications, including early breast cancer detection and the diagnosis of pain dysfunctions. However, the company currently does not have significant operations. Its past business model involved generating revenue through licensing agreements and potentially direct sales of thermal imaging devices. The company's future direction is uncertain, and any potential revitalization would likely require a new business strategy or the acquisition of promising assets.
What do analysts say about WLSI stock?
There is currently no analyst coverage available for Wellstar International, Inc. due to its limited market capitalization and lack of significant operations. The company's financial performance is not tracked by major financial data providers, and there is no consensus view on its future prospects. Investors should conduct their own thorough research and due diligence before considering an investment in WLSI.
What are the main risks for WLSI?
The main risks for Wellstar International, Inc. include its lack of significant operations, limited financial resources, and intense competition in the medical device industry. The company's existing technology may be rendered obsolete by rapid technological advancements, and stringent regulatory requirements could pose additional challenges. An economic downturn could also negatively impact healthcare spending and the demand for the company's products or services. Investing in WLSI carries a high degree of risk and uncertainty.
What are the key factors to evaluate for WLSI?
Wellstar International, Inc. (WLSI) holds an AI score of 48/100 (low). Not financial advice.
How frequently does WLSI data refresh on this page?
WLSI prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven WLSI's recent stock price performance?
Wellstar International, Inc. (WLSI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Potentially valuable intellectual property related to thermal imaging. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WLSI overvalued or undervalued right now?
Valuing Wellstar International, Inc. (WLSI) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying WLSI?
Before investing in Wellstar International, Inc. (WLSI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's lack of significant operations and limited public disclosures.
- AI analysis is pending and may provide additional insights.